(NP (NP The/DT use/NN) (PP of/IN (NP interferon-gamma-treated/JJ U937/NN cells/NNS)) (PP in/IN (NP chemiluminescence/NN assays/NNS)) (SBAR (WHNP-55 0/-NONE-) (S (NP-SBJ *T*-55/-NONE-) (VP to/TO (VP detect/VB (NP (NP-COOD (NP red/JJ cell/NN) ,/, (NP platelet/NN) and/CC (NP granulocyte/NN antibodies/NNS)) (PP of/IN (NP potential/JJ clinical/JJ significance/NN))))))) ./.)
(S (NP-SBJ-56 (NP The/DT (ADJP (ADJP chemiluminescent/JJ) (PRN -LRB-/-LRB- (ADJP CL/JJ) -RRB-/-RRB-)) response/NN) (PP of/IN (NP (NP (NP interferon-gamma-treated/JJ U937/NN) (PRN -LRB-/-LRB- (NP IFN-U937/NN) -RRB-/-RRB-)) cells/NNS)) (PP to/TO (NP sensitized/VBN target/NN cells/NNS))) (VP has/VBZ (VP been/VBN (VP used/VBN (NP-57 *-56/-NONE-) (S (NP-SBJ *-57/-NONE-) (VP to/TO (VP detect/VB (NP-COOD (NP red/JJ cell/NN) ,/, (NP platelet/NN) and/CC (NP granulocyte/NN antibodies/NNS)))))))) ./.)
(S (NP-SBJ-58 (NP A/DT clone/NN) (PP of/IN (NP U937/NN cells/NNS)) (SBAR *ICH*-59/-NONE-)) (VP was/VBD (VP selected/VBN (NP *-58/-NONE-) (SBAR-COOD-59 (SBAR (WHNP-60 which/WDT) (S (NP-SBJ *T*-60/-NONE-) (VP expressed/VBD (NP (NP Fc/NN receptor/NN I/NN) (PRN -LRB-/-LRB- (NP Fc/NN gamma/NN RI/NN) -RRB-/-RRB-))))) and/CC (SBAR (WHNP-61 which/WDT) ,/, (S (PP-TMP after/IN (NP (NP incubation/NN) (PP with/IN (NP IFN-gamma/NN)) (PP-TMP for/IN (NP 72/CD h/NN)))) ,/, (NP-SBJ-62 *T*-61/-NONE-) (VP was/VBD (ADJP-PRD capable/JJ (PP of/IN (S (NP-SBJ *-62/-NONE-) (VP generating/VBG (NP (NP high/JJ levels/NNS) (PP of/IN (NP lucigenin-enhanced/JJ CL/NN))))))))))))) ./.)
(S (NP-SBJ-63 (NP The/DT CL/NN responses/NNS) (PP of/IN (NP-COOD (NP IFN-U937/NN cells/NNS) and/CC (NP peripheral/JJ blood/NN human/JJ monocytes/NNS))) (PP to/TO (NP sensitized/VBN (NP-COOD (NP red/JJ cells/NNS) ,/, (NP platelets/NNS) or/CC (NP granulocytes/NNS))))) (VP were/VBD (ADVP then/RB) (VP compared/VBN (NP *-63/-NONE-))) ./.)
(S (NP-SBJ (NP Assays/NNS) (VP using/VBG (NP-COOD (NP monocytes/NNS) or/CC (NP IFN-U937/NN cells/NNS)))) (VP were/VBD (PP-PRD of/IN (NP (NP comparable/JJ sensitivity/NN) (PP for/IN (NP (NP detection/NN) (PP of/IN (NP (NP antibodies/NNS) (PP against/IN (NP (NP all/DT three/CD types/NNS) (PP of/IN (NP target/NN cell/NN))))))))))) ./.)
(S (PP In/IN (NP addition/NN)) ,/, (NP-SBJ (NP the/DT use/NN) (PP of/IN (NP IFN-U937/NN cells/NNS))) (VP-COOD (VP reduced/VBD (NP interassay/JJ variation/NN)) and/CC (VP simplified/VBD (NP assay/NN performance/NN))) ./.)
(S (NP-SBJ-64 (NP The/DT potential/JJ clinical/JJ usefulness/NN) (PP of/IN (NP these/DT CL/NN assays/NNS))) (VP was/VBD (VP suggested/VBN (NP *-64/-NONE-) (PP by/IN (NP-LGS (NP the/DT ability/NN (S *ICH*-65/-NONE-)) (PP of/IN (NP-COOD both/CC (NP monocytes/NNS) and/CC (NP IFN-U937/NN cells/NNS))) (S-65 (NP-SBJ */-NONE-) (VP to/TO (VP respond/VB (PP to/TO (NP (NP-COOD (NP red/JJ cells/NNS) ,/, (NP platelets/NNS) or/CC (NP granulocytes/NNS)) (VP sensitized/VBN (NP */-NONE-) (PP with/IN (NP (NP sera/NN) (PP from/IN (NP (NP pregnant/JJ women/NNS) (SBAR (WHNP-66 whose/WP$ babies/NNS) (S (NP-SBJ *T*-66/-NONE-) (VP had/VBD (NP-COOD either/CC (NP (NP haemolytic/JJ disease/NN of/IN the/DT newborn/JJ) (PRN -LRB-/-LRB- (NP HDN/NN) -RRB-/-RRB-)) ,/, (NP alloimmune/JJ thrombocytopenia/NN) or/CC (NP alloimmune/JJ neutropenia/NN)) (ADVP respectively/RB)))))))))))))))))) ./.)
(S (PP In/IN (NP addition/NN)) ,/, (NP-SBJ (NP-COOD (NP monocytes/NNS) and/CC (NP IFN-U937/NN cells/NNS)) (NP both/DT)) (VP responded/VBD (PP to/TO (NP (NP red/JJ cells/NNS) (VP sensitized/VBN (NP */-NONE-) (PP with/IN (NP (NP antibodies/NNS) (PP against/IN (NP (NP a/DT variety/NN) (PP of/IN (NP (NP specificities/NNS) (PP of/IN (NP (NP (ADJP-COOD (ADJP assumed/VBN) -LRB-/-LRB- although/IN (ADJP not/RB documented/VBN) -RRB-/-RRB-) clinical/JJ significance/NN) (PP for/IN (NP blood/NN transfusion/NN recipients/NNS)))))))))))))) ./.)
(S (PP In/IN (NP contrast/NN)) ,/, (NP-SBJ-COOD (NP monocytes/NNS) and/CC (NP IFN-U937/NN cells/NNS)) (VP responded/VBD (ADVP only/RB weakly/RB) (PP to/TO (NP (NP red/JJ cells/NNS) (VP sensitized/VBN (NP */-NONE-) (PP-COOD (PP with/IN either/CC (NP (NP anti-D/JJ) (PP in/IN (NP (NP sera/NN) (PP from/IN (NP (NP mothers/NNS) (PP of/IN (NP (NP babies/NNS) (VP unaffected/JJ (NP */-NONE-) (PP by/IN (NP-LGS HDN/NN))))))))))) ,/, or/CC (PP with/IN (NP (NP antisera/NNS) (VP containing/VBG (NP (NP high/JJ titre/NN antibodies/NNS) (PP with/IN (NP (NP specificities/NNS) (VP not/RB (ADVP normally/RB) associated/VBN (NP */-NONE-) (PP with/IN (NP (ADJP significantly/RB reduced/VBN) red/JJ cell/NN survival/NN)))))))))))))) ./.)
